Vita 34 AG (V3V) NPV
- Add to watchlist
- This stock can be held in a
Business summary
Vita 34 AG, formerly, Vita 34 International AG, is a Germany-based company operating in the medical technology sector and acts as a cell bank/stem cell bank. The Company is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. They also allow the growing of whole organs, such as the liver. On average, one out seven individuals, whose cells are stored, receives autologous stem cell transplant by the age of 70. The Company acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The Company operates in Germany, Spain, and Denmark.
Contact details
Important dates
General stock information
- Short code:
- V3V
- ISIN:
- DE000A0BL849
- Market cap:
- €70.91 million
- Shares in issue:
- 17.43 million
- Sector:
- Health Care Services
- Exchange:
- Frankfurt Stock Exchange
- Country:
- Germany
- Currency:
- Euro
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.